-
Sex Differences in Angiotensin II Hypertension in Mice
2026-08-26
Xue, Pamidimukkala, and Hay used radiotelemetry in conscious mice to show that chronic angiotensin II produces a much larger hypertensive response in males than in females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this difference to sex-hormone-dependent regulation, baroreflex resetting, and sympathetic control of arterial pressure.
-
Ultrasound-Triggered Piezo-Nanoplatforms for Epilepsy
2026-08-26
The reference study presents a biomimetic piezoelectric nanoplatform that uses ultrasound to generate localized electrical stimulation without implanted electrodes. By combining neuromodulation with sustained antiepileptic drug delivery, the approach aims to improve seizure control while reducing surgical burden and systemic drug exposure.
-
3X (DYKDDDDK) Peptide: Assay Workflow Guide
2026-08-25
Learn how 3X (DYKDDDDK) Peptide, SKU A6001, can add an orthogonal protein-level readout to viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers construct compatibility, storage, metal-sensitive assays, interpretation, and practical vendor-selection criteria.
-
LINC01977 Super-Enhancer Hijacking in Early LUAD
2026-08-25
Zhang et al. identified super-enhancer hijacking of the lncRNA LINC01977 as a feed-forward mechanism linking TAM2-associated TGF-β signaling to SMAD3-dependent malignancy in early-stage lung adenocarcinoma. The study integrates epigenomic mapping, chromatin-interaction analysis, mechanistic assays, and in vivo models to define a potential vulnerability in lung adenocarcinoma research.
-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-08-24
EZ Cap Cy5 Firefly Luciferase mRNA combines a Cap1-capped, 5-moUTP modified mRNA with Firefly Luciferase and covalent Cy5 labeling. The dual readout separates intracellular RNA delivery from downstream protein expression for mRNA delivery and transfection, translation efficiency assay design, and bioluminescence imaging workflows.
-
GnRH Antagonist Design at Position 3
2026-08-24
Samant and colleagues investigated how replacing position 3 of degarelix with stereochemically distinct 3-(2-methoxy-5-pyridyl)-alanine residues affects GnRH receptor antagonism and in vivo duration. The study combined peptide synthesis, RP-HPLC separation, proteinase K digestion, receptor testing, and a castrated male rat assay to show that the D-configured analog retained potency, whereas both modified analogs were short-acting in vivo.
-
TNF-alpha recombinant murine protein Workflows
2026-08-23
Build reproducible murine cell-culture assays around a highly active trimeric cytokine for apoptosis, inflammation, and receptor-signaling studies. This workflow also shows how TNF-alpha treatment can serve as an orthogonal comparator when investigating the transcription-independent apoptotic response described in recent RNA Pol II research.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Signal to Mechanism
2026-08-22
ARCA Cy5 EGFP mRNA (5-moUTP) enables paired analysis of mRNA delivery, intracellular localization, and functional translation. This guide explains how to convert Cy5 and EGFP signals into mechanistic assay decisions within mammalian-cell and LNP workflows.
-
Z-WEHD-FMK for Caspase-1 and Pyroptosis Research
2026-08-22
Z-WEHD-FMK is a cell-permeable, irreversible inhibitor for dissecting inflammatory caspase activity in pyroptosis, infection, and Golgi-remodeling experiments. This guide translates the HOXC8–caspase-1 lung cancer findings into practical assay designs while distinguishing validated use cases from exploratory applications.
-
Flexible Phages for Rare-Cell Cancer Subtyping
2026-08-21
The reference study uses mechanically flexible M13 phage nanofibers to improve circulating tumor cell capture while limiting white blood cell adsorption. Its combination of affinity-based isolation and immunostaining differentiated breast cancer patients from healthy donors and supported breast cancer subtype classification.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-20
ARCA Cy5 EGFP mRNA (5-moUTP) provides a dual readout for distinguishing cellular delivery from productive translation. Its Cy5 label supports direct tracking, while EGFP expression helps benchmark delivery vehicles, formulation variables, and intracellular trafficking in mammalian cells.
-
URB597: From FAAH Assay to Pain Mechanism
2026-08-20
URB597 and KDS-4103 provide a selective way to interrogate FAAH-dependent anandamide biology. This article translates recent CBD pain research into a compartment-aware assay strategy for endocannabinoid, neuroinflammation, and affective-neuroscience studies.
-
Fluorouracil: From DNA Stress to Tumor Immunity
2026-08-19
Fluorouracil and 5-Fluorouracil are examined here through a mechanistic framework linking thymidylate synthase inhibition, DNA replication stress, and tumor-immune context. The article translates Wnt/β-catenin research into practical decisions for interpreting colon cancer research, breast cancer research, and combination assays.
-
Aprotinin: Protease Control for Better Assays
2026-08-19
Aprotinin, the bovine pancreatic trypsin inhibitor, can function as more than a protease blocker: it is a mechanistic control for separating proteolysis, inflammation, and transcriptional responses. This guide connects A2574 selection and handling with insights from an efficient GRO-seq workflow.
-
CBD, FAAH, and Affective Dimensions of Orofacial Pain
2026-08-18
This 2026 study shows that cannabidiol (CBD) can reduce inflammatory orofacial pain while also improving anxiety-like, depression-like, and cognitive outcomes in mice. Its multilevel design links peripheral FAAH and CB2-related signaling with central CB1, anandamide, and serotonergic mechanisms, providing a useful framework for dissecting sensory and affective pain biology.